Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice - Wikidata - awgldk - TriplyDB

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

http://www.wikidata.org/entity/Q35153847

about

Therapeutic Efficacy of Stem Cells Transplantation in Diabetes: Role of Heme Oxygenase Silibinin inhibits ICAM-1 expression via regulation of N-linked and O-linked glycosylation in ARPE-19 cells.In vitro assessment of mouse fetal abdominal aortic vascular function.Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability.Pharmacological and dietary prevention for colorectal cancer.Social disparities, health risk behaviors, and cancer.Silibinin Inhibits Platelet-Derived Growth Factor-Driven Cell Proliferation via Downregulation of N-Glycosylation in Human Tenon's Fibroblasts in a Proteasome-Dependent Manner Chronic supplementation of paeonol combined with danshensu for the improvement of vascular reactivity in the cerebral basilar artery of diabetic rats Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA).Neurotoxicity of acrylamide in exposed workers Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: an overview.The therapeutic potential of milk thistle in diabetes.Reversibility of endothelial dysfunction in diabetes: role of polyphenols.Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential.Silibinin Regulates Lipid Metabolism and Differentiation in Functional Human Adipocytes.Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells.Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole.Primary Motor Cortex Excitability in Karate Athletes: A Transcranial Magnetic Stimulation Study.Coronary artery spasm related to thiol oxidation and senescence marker protein-30 in aging.Role of Sex Hormones in the Control of Vegetative and Metabolic Functions of Middle-Aged Women.Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease.Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma.Anti-Atherogenic Activity of Polyphenol-Rich Extract from Bee Pollen.The Role of Anabolic Androgenic Steroids in Disruption of the Physiological Function in Discrete Areas of the Central Nervous System.Tauroursodeoxycholic Acid Reduces Arterial Stiffness and Improves Endothelial Dysfunction in Type 2 Diabetic Mice.

P2860

Q26740019-79F9416B-A6AB-4273-A6A8-A2730F274873 Q33852271-4352C45A-C5C7-4619-94E7-58E5033F837C Q34201168-F8510FFE-A9D4-4002-A5CD-20463C4ED881 Q34692362-5D877CF5-81EC-4CAA-8A0C-021C20DF9ACE Q35051366-CE8586AF-A171-4E8A-A549-2E5CD1E72FC3 Q35051412-4FCF012E-E5E4-4E0E-A20E-5AFCB50F0F65 Q36234820-1BDAE3B4-47FA-48BD-AF7E-322F00395F25 Q36432495-B2FD3AF9-B50F-4766-883E-ED5C0E1BA134 Q37727924-877C2A96-B3A6-4445-AEF4-A88ECF22E435 Q38132328-A1FAEA31-E9FC-4745-8022-08C423A2F5D8 Q38137028-DA59D8BF-D254-4325-B6EE-7DF8877DFF4A Q38268147-1DCAF674-ED77-4027-A453-3DBF6148A245 Q38855635-5AF670EE-ABB5-426A-87C2-E1739B8B8097 Q39414338-5FC9AE44-58B8-4A11-B1FB-98346C9D8C5E Q40033823-F71D8B20-8753-4C45-9F82-95D6FADBA59C Q41037704-49E7291B-C6A2-4CEB-9262-08CE2E0D0839 Q41487313-785D5416-630F-4BEC-AE84-1A62549C5019 Q41684442-F2A51BF5-A91D-4559-BD80-76B52C28C0E1 Q41684557-5EEC5059-7BD0-4567-B542-DBA55E9A7714 Q41859845-D1CD5772-4157-4EC8-9BF8-32FE46FD374C Q42372893-E787CD33-D4AF-41D2-8127-4E3714E8C8DF Q42769487-61B995BD-8F66-4722-A83C-1B4AD99B3A0A Q47130202-2678A1A6-9E59-488D-9B64-DEFA675AC7AA Q47156005-F6219A0E-6C55-4A6E-85E4-3C9522385F8A Q47607873-4129E6B4-A1E5-490F-A6C9-2BC17498FC0C Q49990377-C916C554-606C-4BE0-9D7D-B8D3D08DC54E

P2860

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

http://www.wikidata.org/entity/Q35153847

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

@ast

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

@en

type

label

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

@ast

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

@en

prefLabel

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

@ast

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

@en

P1433

Q35153847-C66A4A6B-EE72-472F-9EAC-230A1CE39E80

P1476

Q35153847-F15AB323-9037-4C53-8EF2-A26ACA48A76D

P2093

Q35153847-C1FE635E-CA8E-4C75-AD26-E02219C94F1E

Q35153847-D5F8D7BB-DD16-4A97-8709-D49CFA86C48F

Q35153847-DEDD4566-A52E-49EB-965E-95B9270A81DE

Q35153847-FA4BCD07-5477-485E-A617-92A3294CFE65

P2860

Q35153847-071DA9FA-722F-44B1-BE8C-554E93A17CF1

Q35153847-0A898BB4-9FF6-41FE-B95E-FC496A507642

Q35153847-1897090D-F5C5-41CF-84C7-49D642E5A4DA

Q35153847-19871B14-557C-4548-8A96-53EE59B8955C

Q35153847-256DA898-DE8B-4AE3-A419-44AFA4504DD9

Q35153847-28E33FD3-8E61-4D93-9789-C28E57EB2635

Q35153847-2AC49322-1334-4458-91C9-B8F79D6F6B65

Q35153847-37305B69-EC93-4BE9-A70E-9436E2EF78A9

Q35153847-40FA3CBD-CD45-42B8-AC0C-EA5BADF8A8DC

Q35153847-66266E96-CD3C-4642-AFD9-1BFF507639D6

P2888

Q35153847-1FA5D189-E51C-45E8-9710-D661595C78C0

P304

Q35153847-6E5902FD-D13B-4320-8E6F-77998672DC2A

P31

Q35153847-20DEFAC1-C6C1-444F-8C8E-0A00FD1755ED

P356

Q35153847-5A6C3723-C82A-4A99-86F0-086E8546DDCF

P407

Q35153847-8E36BD96-8246-4761-8B12-EB8DEB75DABE

P478

Q35153847-5E8FF446-42B1-4FD8-8249-22B4208AB145

P50

Q35153847-17F0EAF2-F7E8-4CF3-ABCC-6B3558813D27

Q35153847-24AA48BC-8059-423F-87EB-C62956F5AC17

Q35153847-B073D1B5-C9BA-4BA2-A67A-0F445BA7A327

Q35153847-EB283089-9261-4AC8-B10A-47DFAF2A63E9

P577

Q35153847-ECD3F505-6234-445F-829B-60F694E2EB79

P5875

Q35153847-CD750320-65BD-4606-BD6C-2B6A901C56EE

P6179

Q35153847-A8F3127E-0FE6-40CE-B9B6-56FE19AAB3C9

P698

Q35153847-39496D91-4450-4B9A-9840-9316B1D66D1B

P921

Q35153847-20D1A670-DF5B-47C5-A344-1D2B844E8D34

Q35153847-51C5BA4E-5B07-4EF1-BE21-6C4EA79A3709

P932

Q35153847-CF907BF5-1991-4411-A042-FBC449C1CA66

P356

1475-2840-10-62

P1433

Cardiovascular Diabetology

P1476

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

@en

P2093

Andrea Mangiameli

http://www.w3.org/2001/XMLSchema#string

Giovanni Li Volti

http://www.w3.org/2001/XMLSchema#string

Ilias Siarkos

http://www.w3.org/2001/XMLSchema#string

Vincenzo Urso

http://www.w3.org/2001/XMLSchema#string

P2860

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.

Endothelial function as a functional expression of cardiovascular risk factors.

Polyphenols and prevention of cardiovascular diseases.

The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.

The DDAH/ADMA/NOS pathway.

Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria

Vascular endothelium in atherosclerosis.

P2888

1475-2840-10-62

P304

62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-10-62

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Federico Salomone

Salvatore Salomone

Valeria Sorrenti

P577

2011-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51492166

http://www.w3.org/2001/XMLSchema#string

P6179

1015928851

http://www.w3.org/2001/XMLSchema#string

P698

21756303

http://www.w3.org/2001/XMLSchema#string

P921

P932

3152512

http://www.w3.org/2001/XMLSchema#string